The first batch of drug 2-Deoxy-D-Glucose is expected to be launched next week for COVID patients. It will be in powder form.
The drug has been developed by the Defence Research and Development Organisation, DRDO which recently got the approval for emergency use by the Drugs Controller General of India (DCGI).
